{"id":15240,"date":"2025-01-16T13:11:16","date_gmt":"2025-01-16T21:11:16","guid":{"rendered":"https:\/\/elixirmedical.com\/?page_id=15240"},"modified":"2025-01-24T06:29:02","modified_gmt":"2025-01-24T14:29:02","slug":"us","status":"publish","type":"page","link":"https:\/\/elixirmedical.com\/vi\/us\/","title":{"rendered":"US Home"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANS-
FORMATION<\/font><\/em><\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Unlocked<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At Elixir we believe that only by harnessing the power of transformation can there be real-world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come.<\/p>

We are a company developing disruptive platforms to treat coronary and peripheral artery disease.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANSFORMATION<\/font><\/em>.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TRANS-
FORMA-
TION<\/font><\/em>.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Unlocked.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At Elixir we believe that only by harnessing the power of transformation can there be real world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come.<\/p>

We are a company developing disruptive platforms to treat coronary and peripheral artery disease.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

CVDs are leading cause of death\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t17.9 million lives each year1<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

244.1 million <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tpeople were living with coronary artery disease2<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

About 6 million \n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

patients undergo PCI (Percutaneous Coronary Intervention) every year<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

$407.3 billion<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

in direct and indirect cost in the United States3<\/sup><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

805,000 annual heart attacks in US\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t200,000 are recurrent3<\/sup>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

20% of patients experience an adverse event <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

within 5 years after PCI procedure4<\/sup><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Our technologies<\/i><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

DynamX\u00ae<\/sup> coronary bioadaptor<\/a><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

DynamX bioadaptor is a coronary implant that is designed to not only restore blood flow, but to also unlock and uncage the vessel, allowing the artery to return to its natural physiology, motion and function while DynamX continues to provide dynamic support.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

LITHIX\u2122 HERTZ CONTACT LITHOTRIPSY (HC-IVL) CATHETER<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The LithiX HC-IVL Catheter is designed to use Hertz contact stress to harness the power of physics and mechanics to fracture calcium. It is designed with deliverability, safety and simplicity of use in mind.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

SITE-SPECIFIC ANTITHROMBOTIC THERAPY<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

We developed the world\u2019s first site-specific antithrombotic therapy using two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor, sirolimus. The technology is designed to address challenges associated with percutaneous coronary intervention (PCI), including management of thrombotic and bleeding risk.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\tLearn More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

References<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1<\/span><\/a><\/li>
  2. https:\/\/professional.heart.org\/
    -\/media\/PHD-Files-2\/Science-News\/2\/2022-Heart-and-Stroke-Stat-Update\/2022-Stat-Update-factsheet-GIobal-Burden-of-Disease.pdf<\/a><\/span><\/li>
  3. https:\/\/www.ahajournals.org\/doi\/epub\/
    10.1161\/CIR.0000000000001123<\/a><\/span><\/li>
  4. https:\/\/www.ahajournals.org\/doi\/full\/
    10.1161\/CIRCINTERVENTIONS.114.002230<\/a><\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    1. https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1<\/span><\/a><\/li>
    2. https:\/\/professional.heart.org\/-\/media\/PHD-Files-2\/Science-News\/2\/2022-Heart-and-Stroke-Stat-Update\/2022-Stat-Update-factsheet-GIobal-Burden-of-Disease.pdf<\/a><\/span><\/li>
    3. https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/CIR.0000000000001123<\/a><\/span><\/li>
    4. https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCINTERVENTIONS.114.002230<\/a><\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      PMN 2137 Rev A<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t
      <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      TRANS-FORMATION Unlocked At Elixir we believe that only by harnessing the power of transformation can there be real-world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come. We are a company developing disruptive platforms to treat coronary and peripheral artery disease. TRANSFORMATION. TRANS-FORMA-TION. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-15240","page","type-page","status-publish","hentry"],"yoast_head":"\nCardiovascular Disease | Elixir Medical<\/title>\n<meta name=\"description\" content=\"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elixirmedical.com\/vi\/us\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiovascular Disease | Elixir Medical\" \/>\n<meta property=\"og:description\" content=\"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elixirmedical.com\/vi\/us\/\" \/>\n<meta property=\"og:site_name\" content=\"Elixir Medical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/elixirmedicalinc\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-24T14:29:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image-1024x757.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"757\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/\",\"name\":\"Cardiovascular Disease | Elixir Medical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\",\"datePublished\":\"2025-01-16T21:11:16+00:00\",\"dateModified\":\"2025-01-24T14:29:02+00:00\",\"description\":\"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/#breadcrumb\"},\"inLanguage\":\"vi-VN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi-VN\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\",\"contentUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Dynamx-Bioadaptor-Main-Image.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/us\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/\",\"name\":\"Elixir Medical\",\"description\":\"Transformation Unlocked\",\"publisher\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi-VN\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#organization\",\"name\":\"Elixir Medical\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi-VN\",\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/New-Elixir-Logo.png\",\"contentUrl\":\"https:\\\/\\\/elixirmedical.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/New-Elixir-Logo.png\",\"width\":5550,\"height\":1870,\"caption\":\"Elixir Medical\"},\"image\":{\"@id\":\"https:\\\/\\\/elixirmedical.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/elixirmedicalinc\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiovascular Disease | Elixir Medical","description":"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elixirmedical.com\/vi\/us\/","og_locale":"vi_VN","og_type":"article","og_title":"Cardiovascular Disease | Elixir Medical","og_description":"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.","og_url":"https:\/\/elixirmedical.com\/vi\/us\/","og_site_name":"Elixir Medical","article_publisher":"https:\/\/www.facebook.com\/elixirmedicalinc","article_modified_time":"2025-01-24T14:29:02+00:00","og_image":[{"width":1024,"height":757,"url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image-1024x757.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/elixirmedical.com\/vi\/us\/","url":"https:\/\/elixirmedical.com\/vi\/us\/","name":"Cardiovascular Disease | Elixir Medical","isPartOf":{"@id":"https:\/\/elixirmedical.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elixirmedical.com\/vi\/us\/#primaryimage"},"image":{"@id":"https:\/\/elixirmedical.com\/vi\/us\/#primaryimage"},"thumbnailUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png","datePublished":"2025-01-16T21:11:16+00:00","dateModified":"2025-01-24T14:29:02+00:00","description":"Elixir Medical is a a developer of technologies to treat cardiovascular disease. This is the United States version of the website.","breadcrumb":{"@id":"https:\/\/elixirmedical.com\/vi\/us\/#breadcrumb"},"inLanguage":"vi-VN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elixirmedical.com\/vi\/us\/"]}]},{"@type":"ImageObject","inLanguage":"vi-VN","@id":"https:\/\/elixirmedical.com\/vi\/us\/#primaryimage","url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png","contentUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/Dynamx-Bioadaptor-Main-Image.png"},{"@type":"BreadcrumbList","@id":"https:\/\/elixirmedical.com\/vi\/us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elixirmedical.com\/vi\/"},{"@type":"ListItem","position":2,"name":"US Home"}]},{"@type":"WebSite","@id":"https:\/\/elixirmedical.com\/vi\/#website","url":"https:\/\/elixirmedical.com\/vi\/","name":"Elixir Medical","description":"Transformation Unlocked","publisher":{"@id":"https:\/\/elixirmedical.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elixirmedical.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi-VN"},{"@type":"Organization","@id":"https:\/\/elixirmedical.com\/vi\/#organization","name":"Elixir Medical","url":"https:\/\/elixirmedical.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi-VN","@id":"https:\/\/elixirmedical.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/New-Elixir-Logo.png","contentUrl":"https:\/\/elixirmedical.com\/wp-content\/uploads\/2023\/09\/New-Elixir-Logo.png","width":5550,"height":1870,"caption":"Elixir Medical"},"image":{"@id":"https:\/\/elixirmedical.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/elixirmedicalinc"]}]}},"acf":[],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/pages\/15240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/comments?post=15240"}],"version-history":[{"count":0,"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/pages\/15240\/revisions"}],"wp:attachment":[{"href":"https:\/\/elixirmedical.com\/vi\/wp-json\/wp\/v2\/media?parent=15240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}